AVDL

AVDL

USD

Avadel Pharmaceuticals plc Ordinary Share

$9.770+0.250 (2.626%)

Reaalajas hind

Healthcare
Drug Manufacturers - Specialty & Generic
Iirimaa

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$9.520

Kõrge

$9.790

Madal

$9.430

Maht

0.27M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

968.5M

Tööstusharu

Drug Manufacturers - Specialty & Generic

Riik

Ireland

Kauplemisstatistika

Keskmine maht

1.36M

Börs

NGM

Valuuta

USD

52 nädala vahemik

Madal $6.38Praegune $9.770Kõrge $17.3

Seotud uudised

BusinessWire

ASL Strategic Value Fund Issues Open Letter to Avadel Shareholders

Calls for all Avadel Shareholders to vote AGAINST all Director Nominees at the upcoming Annual Meeting ASL Strategic Value Fund, LP (together with its affiliates, "ASL Strategic Value Fund" or "we"), a significant

Vaata rohkem
ASL Strategic Value Fund Issues Open Letter to Avadel Shareholders
GlobeNewswire

Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation

DUBLIN, June 30, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (NASDAQ:AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced that, on Friday, June 27, 2025, the U.S.

Vaata rohkem
Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.